Contact this trialFirst, we need to learn more about you.
SGLT2-Inhibitor
SGLT2-Inhibitors for Sleep Apnea in Heart Failure
Recruiting1 awardPhase 2
New York, New York
This trial is investigating whether a new drug class called Sodium glucose co-transporter 2 (SGLT2)-Inhibitors can help in the treatment of sleep disordered breathing.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.